Works matching IS 14712172 AND DT 2025 AND VI 26 AND IP 1


Results: 42
    1

    Incidence of severe adverse events in cancer patients after treatment with immune-checkpoint inhibitors during the COVID- 19 pandemic.

    Published in:
    BMC Immunology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s12865-025-00711-w
    By:
    • Kimura, Sakiko;
    • Katsuya, Hiroo;
    • Nakashima, Chiho;
    • Sueoka-Aragane, Naoko;
    • Hayashida, Koji;
    • Sasaki, Kazumi;
    • Sogawa, Rintaro;
    • Furuno, Tatsuya;
    • Yamauchi, Moriyasu;
    • Sugiyama, Yoichiro;
    • Noshiro, Hirokazu;
    • Esaki, Motohiro;
    • Noguchi, Mitsuru;
    • Takahashi, Hirokazu;
    • Anzai, Keizo;
    • Yokoyama, Masatoshi;
    • Sugita, Kazunari;
    • Yamashita, Yoshio;
    • Kawaguchi, Atsushi;
    • Kimura, Shinya
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Alpha-gal allergy in a South Asian country.

    Published in:
    BMC Immunology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s12865-025-00717-4
    By:
    • Dasanayake, Dhanushka;
    • Karunatilake, Chandima;
    • Karunaratne, Chathurika;
    • Fernando, Nishadini;
    • Iddagoda, Janitha;
    • de Silva, Rajiva
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42